plasma
-
not specified
Microarray; RNase R Treatment; RT-qPCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis
CRC-specific biomarker for early diagnosis; high diagnostic ability to predict CRC from CRA patients and healthy controls
hsa_circ_103627 is up-regulated in CRC plasma and contributes to a three-circRNA circulating panel with strong diagnostic performance for early CRC detection against CRA and healthy controls. The study focused on biomarker performance and stability rather than mechanistic validation.
0.5963
Circulating cell-free circRNA panel predicted tumorigenesis and development of colorectal cancer.
combined biological and clinical study